WO2012046251A2 - Novel form of ranelic acid - Google Patents
Novel form of ranelic acid Download PDFInfo
- Publication number
- WO2012046251A2 WO2012046251A2 PCT/IN2011/000696 IN2011000696W WO2012046251A2 WO 2012046251 A2 WO2012046251 A2 WO 2012046251A2 IN 2011000696 W IN2011000696 W IN 2011000696W WO 2012046251 A2 WO2012046251 A2 WO 2012046251A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- ranelic
- reaction mixture
- strontium
- base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Definitions
- the present invention relates to an unsolvated form of ranelic acid and the process for the preparation thereof.
- Ranelic acid is represented by the structure:
- Ranelic acid is an intermediate used in the synthesis of strontium ranelate.
- Strontium ranelate is the bis strontium (II) salt of ranelic acid and is used in the treatment of osteoporosis.
- United States Patent No. 5128367 discloses ranel ic acid and process for preparing ranelic acid.
- the US'367 patent provides a process for preparation of ranelic acid starting from tetraester involving heating the tetraester at reflux in the presence of sodium hydroxide in an aqueous alcoholic medium, fol lowed by hydrolysis using a sulfonic acid resin. The residue is recrystallized to obtain ranel ic acid.
- the present invention relates to an unsolyated form of ranelic acid.
- the present invention relates to novel form of ranelic acid hydrate wherein the compound exhibits at least any one of the following characteristics : a) X-ray powder diffraction having characteristic peaks expressed in degrees 2 ⁇ ⁇ 0.2° at about 13.3, 14.59, 21 .19, 24.42, 26.24, 34.42;
- the present invention provides a process for the preparation of ranelic acid comprising:
- R, Ri, R 2 , and R 3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, with a base in a solvent to obtain a reaction mixture; and b) subjecting the reaction mixture to treatment with an acid to precipitate ranelic acid.
- the present invention provides a process for the preparation of ranelic acid comprising :
- R, Rj, R 2 , and R 3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, with a base in a solvent to obtain a reaction mixture;
- reaction mixture b) subjecting the reaction mixture to treatment with acid to adjust pH of reaction mixture to 1 or less than 1 .
- the present invention provides a process for preparation of strontium ranelate comprising reacting ranelic acid with strontium salt in the presence of a base.
- the present invention provides a process for purifying strontium ranelate comprising treating strontium ranelate with an organic acid and or water.
- the present invention provides strontium ranelate containing lithium content less than 60 ppm.
- Fig. 1 represents an XRD diffractogram of ranelic acid of the present invention
- Fig. 2 represents a DSC thermogram of ranelic acid of the present invention
- Fig. 3 represents a TGA thermogram of ranelic acid of the present invention
- Fig. 4 represents an XRD diffractogram of amorphous strontium ranelate of the present invention.
- Fig. 5 represents TGA of amorphous strontium ranelate of the present invention.
- the present invention relates to an unsolvated form of ranelic acid.
- Ranelic acid is a useful intermediate in the preparation of strontium ranelate.
- unsolvated refers to the absence of a complex of ranelic acid with one or more pharmaceutically acceptable solvent molecules, for example tetrahydrofuran, ethanol, acetone and the like.
- hydrate refers to complex with water molecule.
- the present invention relates to a novel hydrate form of ranelic acid characterized by at least one of the following:
- XPERT-PRO (PANalytical) scanning parameters start position [°2Th.] 2.01 and end position [°2Th.] 49.98.
- Ranelic acid is further characterized by DSC thermogram having two endothermic peaks one at 78.39°C and another peak at 154.68°C.
- Ranelic acid is further characterized by differential scanning calorimetry (DSC) with five endothermic curves.
- the first endothermic curve is at about 78.39°C and onset of 50.79°C and endset of 94.38°C.
- the second endothermic curve is at about 13 1 .91 °C and onset of 1 19.75°C and endset of 138.04°C.
- the third endothermic curve is at about 154.68°C and onset of 144.67°C and endset of 160.10°C.
- the fourth endothermic curve is at about 169.20°C and onset of about 163.78°C and endset of about 1 74.94°C and the fifth curve is at 178.34°C with an onset of about 1 77.23°C and an endset of about 179.55°C.
- the DSC thermogram which is substantially in accordance with Fig 2, is measured by a Differential Scanning Calorimeter (DSC 822, Mettler Toledo) at a scan rate of 10°C per minute with an Indium standard.
- the present invention further characterizes the novel form by thermogravi metric analysis, (TGA) thermogram, which is substantially in accordance with Fig.3, shows a weight loss of about 9.39 percent up to a temperature of about 100°C and recorded on a TGA Q500 V 20.6 in a platinum pan with a temperature rise of about 10°C per minute in the range of about 30°C to about 350°C.
- TGA thermogravi metric analysis
- the present invention provides a process for the preparation of ranel ic acid comprising:
- R, Ri, R 2 , and R 3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, optionally susbstituted benzyl in the presence of a base in a solvent to obtain a reaction mixture;
- linear or branched C I -6 alkyl includes groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, ter-butyl, n-pentyl.
- C3-C 12 cyclic group includes groups such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl.
- substituted C3-C 12 cycloalkyl includes groups which have replaced hydrogen atom to any carbon of the cycloalkyl with a halogen, alkyl, substituted alkyl, aryl.
- optionally substituted benzyl means benzyl which is optionally substituted with halo, alkyl, alkoxy or nitro group wherein halo includes CI, Br, I; alkyl includes methyl, ethyl, propyl, butyl; alkoxy includes methoxy, ethoxy, propoxy.
- the solvent is selected from the group consisting of water, water miscible solvents and mixtures thereof.
- Water miscible solvents include cyclic ether such as tetrahydrofuran, 1 ,4-dioxane, nitrile such as acetonitrile, and ketones such as acetone, methyl isobutyl ketone.
- the solvent is a mixture of water and tetrahydrofuran.
- the base is selected from the group consisting of inorganic base such as lithium carbonate, lithium hydroxide monohydrate, calcium hydroxide, cesium hydroxide and mixtures thereof.
- the base is lithium hydroxide monohydrate.
- the addition of base results in an exothermic reaction.
- the addition is therefore carried out over a period of about 45 minutes to about 1 hour.
- the reaction time can vary from between 20 hours to about 30 hours.
- the reaction transpires between 21 hours to 23 hours.
- the reaction is carried out at a temperature of about 0°C to about 30°C.
- acids are selected from strong acids selected from the group of mineral acids such as sulphuric acid, phosphoric acid, hydrochloric acid and organic acids such as methane sulfonic acid, trifluoromethane sulfonic acid.
- acid is sulfuric acid.
- reaction mixture is stirred for about 30 minutes to about 1 hour.
- the reaction mixture is stirred for about 30 minutes.
- Solid ranelic acid is isolated by methods known in the art such as filtration concentration, centrifugation and the like.
- the present invention relates to a process of preparation of novel unsolvated form of ranelic acid comprising:
- reaction mixture aqueous solution of lithium hydroxide to obtain a reaction mixture; and b) subjecting the reaction mixture to treatment with sulfuric acid.
- the solution is cooled to a temperature of about 5°C to about 10°C and at this temperature a solution lithium hydroxide is added slowly.
- the reaction is stirred and maintained for about 1 5 hours to about 30 hours.
- the reaction is stirred and maintained for about 1 8 hours to about 23 hours.
- the reaction mixture is acidified using 10% sulfuric acid and the product from the reaction mixture is filtered or extracted into a suitable solvent selected from ethylacetate, methyl ethyl ketone, methyl isobutyl ketone, methyl tertiary butyl ether.
- a suitable solvent selected from ethylacetate, methyl ethyl ketone, methyl isobutyl ketone, methyl tertiary butyl ether.
- the raneiic acid is extracted with ethyl acetate.
- Solid raneiic acid is isolated by methods known in the art such as filtration, concentration, centrifugation and the like.
- the present invention provides a process of preparation of raneiic acid of formula II
- R, R l , R2, and R3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, in the presence of a base in a solvent to obtain a reaction mixture;
- reaction mixture b) subjecting the reaction mixture to treatment with acid to adjust pH of reaction mixture to 1 or less than 1.
- R, R l , R2, and R3 are as described above.
- reaction may be carried out as described previously in the earlier sections.
- the present invention relates to a process of preparation of ranelic acid comprising:
- reaction mixture with an aqueous solution of lithium hydroxide to obtain a reaction mixture; and b) subjecting the reaction mixture to treatment with sulfuric acid to adjust pH of reaction mixture to less than 1 .
- the process in a) involves preparation of a solution of methyl 5-[bis(2- ethoxy-2-oxoethyl) amino]-4-cyano-3-(2-methoxy-2-oxoethyl)-2-thiophenecarboxylate, of formula III in tetrahydrofuran .
- An aqueous solution of lithium hydroxide is added to the above ester solution. The addition is carried out at a temperature of about 5- 10°C.
- the process in b) involves addition of sulfuric acid.
- the addition is carried out to adjust the pH of the solution to about less than 1 .
- the precipitated ranelic acid is isolated by filtration, centrifugation or extraction. Preferably the precipitated ranelic acid is extracted and isolated.
- Ranelic acid obtained by the present invention is an unsolvated form and has purity greater than 98%.
- ranelic acid obtained by the present invention has purity greater than 99%.
- the novel form of ranelic acid obtained is a hydrate and is stable at room temperature.
- ranelic acid obtained by the present invention can serve as a useful intermediate in the preparation of active pharmaceutical ingredient.
- the present invention provides process for the preparation of strontium ranelate from ranelic acid, comprising reacting ranelic acid with strontium salt in the presence of a base.
- ranelic acid used is the isolated solid form.
- hydrate of ranelic acid Preferably hydrate of ranelic acid.
- the above reaction may be carried out in presence of water or alcoholic solvents such as methanol.
- the solvent is water.
- the base may be selected from inorganic or organic bases such as hydroxides such as sodium hydroxide, potassium hydroxide, lithium hydroxide, carbonates such as sodium carbonate lithium carbonate, potassium carbonate, bicarbonates such as sodium bicarbonate, potassium bicarbonate.
- the inorganic base is lithium hydroxide.
- the organic bases may be selected from the group consisting of pyridine, picoline, quinoline, piperdine, pyrrolidine, N-methylmorphline, amine such as triethylamine and diisopropyl amine and combination thereof.
- the base is lithium hydroxide.
- the strontium salt may be selected from strontium chloride, strontium bromide, strontium sulfate, strontium acetate, strontium carbonate, strontium oxalate, strontium nitrate and a mixture thereof.
- the strontium salt is strontium chloride hexahydrate.
- the above reaction mixture is stirred for a period of about 10 hours to about 30 hours. Preferably, the reaction mixture is stirred for about 15 hours to about 20 hours.
- the reaction transpires at a temperature of about 25°C to about 30°C.
- the precipitate of distrontium salt of 5-[bis (carboxymethyl) amino]-2-carboxy-4-cyano-3- thiopheneacetic acid octahydrate can be isolated by techniques known in the art such as filtration, centrifugation.
- the present invention provides process for the preparation of amorphous strontium ranelate from ranelic acid, comprising reacting ranelic acid with anhydrous strontium salt in the presence of base.
- the ranelic acid used is the unsolvated form.
- hydrate of ranelic acid Preferably hydrate of ranelic acid.
- the base may be selected from inorganic or organic bases such as hydroxides, carbonates, bicarbonates.
- the inorganic base is lithium hydroxide.
- the organic bases may be selected from the group consisting of amine, pyridine, picol ine, quinoline, piperidine, pyrrolidine, N-methylmorphline, and combination thereof.
- the base is diisopropyl amine.
- the above reaction may be carried out in presence of water miscible solvents for example alcoholic solvents such as methanol, ethanol, isopropanol and the like.
- the solvent is methanol.
- the strontium salt may be selected from strontium chloride, strontium bromide, strontium sulfate, strontium acetate, strontium carbonate, strontium oxalate, strontium nitrate and a mixture thereof.
- the strontium salt is strontium chloride anhydrous.
- strontium chloride anhydrous is dissolved in methanol and to this diisopropyl amine is added. Then this solution is added to a solution of ranelic acid in methanol. The reaction is stirred and maintained for a period of about 30 hours to about 50 hours. Preferably the reaction is stirred and maintained for about 45 hours to 49 hours.
- the precipitate of distrontium salt of 5-[bis (carboxymethyl) amino]-2- carboxy-4-cyano-3-thiopheneacetic acid can be isolated by techniques known in the art such as filtration, centrifugation.
- amorphous strontium ranelate is characterized by an X-ray diffraction pattern, substantially in accordance with Fig. 4.
- amorphous strontium ranelate is characterized by thermogravimetric analysis, (TGA) thermogram, which is substantially in accordance with Fig 5., shows a weight loss of 14.5 percent up to a temperature of about 150°C and recorded on a TGA Q500 V 20.6 in a platinum pan with a temperature rise of about 10°C per minute in the range of about 30°C to about 350°C.
- TGA thermogravimetric analysis
- the present invention relates to a process for purification of strontium ranelate comprising treatment of strontium ranelate with water or an organic acid, for example, acetic acid, lactic acid, malonic acid, tartaric acid, oxalic acid or a mixture thereof.
- the acid is oxalic acid, advantageously to be used as 1 % aqueous solution.
- the purification can be carried out preferably by subjecting to a slurrying step carried out at temperature between the range of about 15°C to about 40°C, preferably at about 20°C to about 30°C resulting into removal of lithium.
- the present invention relates to strontium ranelate containing lithium content less than 60 parts per million (ppm).
- the present invention relates to strontium ranelate containing lithium content less than 20 parts per million (ppm).
- the present invention relates to strontium ranelate containing lithium content less than 10 parts per million (ppm).
- Strontium ranelate obtained from ranelic acid of the present invention has purity greater than 99.0% as measured by high performance liquid chromatography (HPLC).
- the lower layer was acidified with 10% sulfuric acid to bring the pH to about less than 1 .
- the reaction mass was further stirred for about 30 minutes. Then the reaction mass was extracted with ethyl acetate. Ethyl acetate layers were pooled and distilled to obtain solid ranelic acid.
- Strontium ranelate octahydrate 50 g was suspended in purified water (500 ml), and the contents were stirred at 25-30 °C for 10 min. To this 1 .0% oxalic acid (0.5 g) was added and the content was stirred for 4.0 h at 25-30°C. The product was filtered and washed with purified water. The wet cake was added into purified water and the content was stirred for 1 .0 h at 25-30°C. The product was filtered and washed with puri fied water.
- the product was dried at 30°C -35°C under reduced pressure ( ⁇ 20mm Hg) to obtain 45g of strontium ranelate (0.9 w/w based on strontium ranelate octahydrate). Li content ⁇ 13 ppm. Loss on drying not more than 23.5%, HPLC purity>99%.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to an unsolvated form of ranelic acid and the process for the preparation thereof.
Description
PRIORITY
[0001] This application claims the benefit of ΓΝ 2801/MUM/201 filed on
October 8, 2010, the content of which is incorporated herein by reference.
FIELD OF INVENTION
[0002] The present invention relates to an unsolvated form of ranelic acid and the process for the preparation thereof.
BACKGROUND OF THE INVENTION.
[0003] Ranelic acid is represented by the structure:
I
[0004] Ranelic acid is an intermediate used in the synthesis of strontium ranelate.
[0005] Strontium ranelate is the bis strontium (II) salt of ranelic acid and is used in the treatment of osteoporosis.
[0006] United States Patent No. 5128367 (the US'367 patent) discloses ranel ic acid and process for preparing ranelic acid. The US'367 patent provides a process for preparation of ranelic acid starting from tetraester involving heating the tetraester at reflux in the presence of sodium hydroxide in an aqueous alcoholic medium, fol lowed by hydrolysis using a sulfonic acid resin. The residue is recrystallized to obtain ranel ic acid.
[0007] The known methods may involve the use of expensive resins and crystallization operations, and the subsequent low yield reported as low as 70%.
[0008] There remains a need to provide a process for a more direct preparation of pure ranelic acid, which results in good yield and high purity, from a reaction, which is cost effective, thus minimizing additional operations for treatment such as crystallization, purification.
SUMMARY OF THE INVENTION
[0009] The present invention relates to an unsolyated form of ranelic acid.
[0010] The present invention relates to novel form of ranelic acid hydrate wherein the compound exhibits at least any one of the following characteristics : a) X-ray powder diffraction having characteristic peaks expressed in degrees 2Θ ±0.2° at about 13.3, 14.59, 21 .19, 24.42, 26.24, 34.42;
b) DSC thermogram having one endothermic peak at 78.39°C and another peak at 154.68°C.
c) TGA thermogram showing a weight loss of about 9.39 percent up to a temperature of 100°C.
[0011] The present invention provides a process for the preparation of ranelic acid comprising:
a) reacting a tetraester of formula II
wherein R, Ri, R2, and R3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, with a base in a solvent to obtain a reaction mixture; and
b) subjecting the reaction mixture to treatment with an acid to precipitate ranelic acid.
[0012] In yet another embodiment, the present invention provides a process for the preparation of ranelic acid comprising :
a) reacting a tetraester of formula II
wherein R, Rj, R2, and R3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, with a base in a solvent to obtain a reaction mixture; and
b) subjecting the reaction mixture to treatment with acid to adjust pH of reaction mixture to 1 or less than 1 .
[0013] In one embodiment, the present invention provides a process for preparation of strontium ranelate comprising reacting ranelic acid with strontium salt in the presence of a base.
[0014] In another embodiment, the present invention provides a process for purifying strontium ranelate comprising treating strontium ranelate with an organic acid and or water.
[0015] The present invention provides strontium ranelate containing lithium content less than 60 ppm.
BRIEF DESCRIPTION OF DRAWINGS
[0016] Fig. 1 represents an XRD diffractogram of ranelic acid of the present invention
[0017] Fig. 2 represents a DSC thermogram of ranelic acid of the present invention
[0018] Fig. 3 represents a TGA thermogram of ranelic acid of the present invention
[0019] Fig. 4 represents an XRD diffractogram of amorphous strontium ranelate of the present invention.
[0020] Fig. 5 represents TGA of amorphous strontium ranelate of the present invention.
DETAILED DESCRIPTION OF THE INVENTION
[0021] The present invention relates to an unsolvated form of ranelic acid.
Ranelic acid is a useful intermediate in the preparation of strontium ranelate.
[0022] The term "unsolvated" refers to the absence of a complex of ranelic acid with one or more pharmaceutically acceptable solvent molecules, for example tetrahydrofuran, ethanol, acetone and the like.
[0023] The term hydrate refers to complex with water molecule.
[0024] The present invention relates to a novel hydrate form of ranelic acid characterized by at least one of the following:
a) X-ray powder diffraction patterns having characteristic peaks expressed in degrees 20 ±0.2° at about 13.3, 14.59, 21 . 19, 24.42, 26.24, 34.42;
b) DSC thermogram having one endothermic peak at 78.39°C and another peak at 154.68°C; and
c) TGA thermogram showing a weight loss of about 9.39 percent up to a temperature of 100°C.
[0025] X-Ray Powder were performed on ARL X-Ray Diffractometer model
XPERT-PRO (PANalytical) scanning parameters start position [°2Th.] 2.01 and end position [°2Th.] 49.98.
[0026] Ranelic acid is further characterized by DSC thermogram having two endothermic peaks one at 78.39°C and another peak at 154.68°C.
[0027] Ranelic acid is further characterized by differential scanning calorimetry (DSC) with five endothermic curves. The first endothermic curve is at about 78.39°C and onset of 50.79°C and endset of 94.38°C. The second endothermic curve is at about 13 1 .91 °C and onset of 1 19.75°C and endset of 138.04°C.The third endothermic curve is at about 154.68°C and onset of 144.67°C and endset of 160.10°C. The fourth endothermic curve is at about 169.20°C and onset of about 163.78°C and endset of about 1 74.94°C and the fifth curve is at 178.34°C with an onset of about 1 77.23°C and an endset of about 179.55°C. The DSC thermogram, which is substantially in accordance with Fig 2, is measured by a Differential Scanning Calorimeter (DSC 822, Mettler Toledo) at a scan rate of 10°C per minute with an Indium standard.
[0028] The present invention further characterizes the novel form by thermogravi metric analysis, (TGA) thermogram, which is substantially in accordance with Fig.3, shows a weight loss of about 9.39 percent up to a temperature of about 100°C and recorded on a TGA Q500 V 20.6 in a platinum pan with a temperature rise of about 10°C per minute in the range of about 30°C to about 350°C.
[0029] The present invention provides a process for the preparation of ranel ic acid comprising:
a) reacting a tetraester of formula II
wherein R, Ri, R2, and R3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, optionally susbstituted benzyl in the presence of a base in a solvent to obtain a reaction mixture; and
b) subjecting the reaction mixture to treatment with an acid to precipitate ranelic acid.
[0030] The term "linear or branched C I -6 alkyl" includes groups such as methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, ter-butyl, n-pentyl. The term C3-C 12 cyclic group includes groups such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl.
[0031] The term "substituted C3-C 12 cycloalkyl" includes groups which have replaced hydrogen atom to any carbon of the cycloalkyl with a halogen, alkyl, substituted alkyl, aryl.
[0032] The term "optionally substituted benzyl" means benzyl which is optionally substituted with halo, alkyl, alkoxy or nitro group wherein halo includes CI, Br, I; alkyl includes methyl, ethyl, propyl, butyl; alkoxy includes methoxy, ethoxy, propoxy.
[0033] In a) of the process above, the solvent is selected from the group consisting of water, water miscible solvents and mixtures thereof. Water miscible solvents include cyclic ether such as tetrahydrofuran, 1 ,4-dioxane, nitrile such as acetonitrile, and ketones such as acetone, methyl isobutyl ketone. Preferably the solvent is a mixture of water and tetrahydrofuran.
[0034] The base is selected from the group consisting of inorganic base such as lithium carbonate, lithium hydroxide monohydrate, calcium hydroxide, cesium hydroxide and mixtures thereof. Preferably, the base is lithium hydroxide monohydrate.
[0035] The addition of base results in an exothermic reaction. The addition is therefore carried out over a period of about 45 minutes to about 1 hour. The reaction time can vary from between 20 hours to about 30 hours. Preferably, the reaction transpires between 21 hours to 23 hours.
[0036] The reaction is carried out at a temperature of about 0°C to about 30°C.
Preferably the reaction is carried out at temperature of about 5°C to about 10°C.
[0037] In b) of the process above, acids are selected from strong acids selected from the group of mineral acids such as sulphuric acid, phosphoric acid, hydrochloric acid and organic acids such as methane sulfonic acid, trifluoromethane sulfonic acid. Preferably the acid is sulfuric acid.
[0038] The reaction mixture is stirred for about 30 minutes to about 1 hour.
Preferably, the reaction mixture is stirred for about 30 minutes.
[0039] Solid ranelic acid is isolated by methods known in the art such as filtration concentration, centrifugation and the like.
[0040] In preferred embodiment, the present invention relates to a process of preparation of novel unsolvated form of ranelic acid comprising:
a) reacting methyl 5-[bis(2-ethoxy-2-oxoethyl) amino]-4-cyano-3-(2-methoxy-2- oxoethyl)-2-thiophenecarboxylate, compound of formula III, in tetrahydrofuran,
with an aqueous solution of lithium hydroxide to obtain a reaction mixture; and b) subjecting the reaction mixture to treatment with sulfuric acid.
[0041] In a) of the immediate process above, methyl 5-[bis(2-ethoxy-2- oxoethyl) amino]-4-cyano-3-(2-methoxy-2-oxoethyl)-2-thiophenecarboxylate, compound of formula III is dissolved in tetrahydrofuran.
[0042] The above solution is cooled to a temperature of about 0°C to about
20°C. Preferably the solution is cooled to a temperature of about 5°C to about 10°C and at
this temperature a solution lithium hydroxide is added slowly. The reaction is stirred and maintained for about 1 5 hours to about 30 hours. Preferably the reaction is stirred and maintained for about 1 8 hours to about 23 hours.
[0043] In b) of the process above, the reaction mixture is acidified using 10% sulfuric acid and the product from the reaction mixture is filtered or extracted into a suitable solvent selected from ethylacetate, methyl ethyl ketone, methyl isobutyl ketone, methyl tertiary butyl ether. Preferably the raneiic acid is extracted with ethyl acetate.
[0044] Solid raneiic acid is isolated by methods known in the art such as filtration, concentration, centrifugation and the like.
[0045] In one embodiment, the present invention provides a process of preparation of raneiic acid of formula II
wherein R, R l , R2, and R3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, in the presence of a base in a solvent to obtain a reaction mixture; and
b) subjecting the reaction mixture to treatment with acid to adjust pH of reaction mixture to 1 or less than 1.
wherein R, R l , R2, and R3 are as described above.
[0046] In a) of the immediate process above, the reaction may be carried out as described previously in the earlier sections.
[0047] The process in b) above, a solution of sulfuric acid is added to obtain a pH of less than 1.
[0048] It has been surprisingly found that although the product precipitates at acidic pH, maximum precipitation occurs by adjusting pH to about 1 or about less than 1 . The acidic reaction mixture is stirred for about 30 minutes to about 1 hour. Preferably the reaction mixture is stirred for about 30 minutes. Raneiic acid is filtered or extracted into a
suitable solvent selected from ethylacetate, methyl ethyl ketone, methyl isobutyl ketone, methyl tertiary butyl ether. Preferably ranelic acid is extracted with ethyl acetate.
[0049] In a preferred embodiment, the present invention relates to a process of preparation of ranelic acid comprising:
a) reacting methyl 5-[bis(2-ethoxy-2-oxoethyl) amino]-4-cyano-3-(2-methoxy-2- oxoethyl)-2-thiophenecarboxylate, compound of formula III, in tetrahydrofuran,
with an aqueous solution of lithium hydroxide to obtain a reaction mixture; and b) subjecting the reaction mixture to treatment with sulfuric acid to adjust pH of reaction mixture to less than 1 .
[0050] The process in a) involves preparation of a solution of methyl 5-[bis(2- ethoxy-2-oxoethyl) amino]-4-cyano-3-(2-methoxy-2-oxoethyl)-2-thiophenecarboxylate, of formula III in tetrahydrofuran . An aqueous solution of lithium hydroxide is added to the above ester solution. The addition is carried out at a temperature of about 5- 10°C.
[0051] The process in b) involves addition of sulfuric acid. The addition is carried out to adjust the pH of the solution to about less than 1 . The precipitated ranelic acid is isolated by filtration, centrifugation or extraction. Preferably the precipitated ranelic acid is extracted and isolated.
[0052] The product was isolated at different acidic pH's and the analysis is as shown in Table 1 .
[0053] Ranelic acid obtained by the present invention is an unsolvated form and has purity greater than 98%.
[0054] Preferably ranelic acid obtained by the present invention has purity greater than 99%.
[0055] In one embodiment, the novel form of ranelic acid obtained is a hydrate and is stable at room temperature.
[0056] The ranelic acid obtained by the present invention can serve as a useful intermediate in the preparation of active pharmaceutical ingredient.
[0057] In one embodiment, the present invention provides process for the preparation of strontium ranelate from ranelic acid, comprising reacting ranelic acid with strontium salt in the presence of a base.
[0058] In one embodiment the ranelic acid used is the isolated solid form.
Preferably hydrate of ranelic acid.
[0059] The above reaction may be carried out in presence of water or alcoholic solvents such as methanol. Preferably the solvent is water.
[0060] The base may be selected from inorganic or organic bases such as hydroxides such as sodium hydroxide, potassium hydroxide, lithium hydroxide, carbonates such as sodium carbonate lithium carbonate, potassium carbonate, bicarbonates such as sodium bicarbonate, potassium bicarbonate. Preferably the inorganic base is lithium hydroxide. The organic bases may be selected from the group consisting of pyridine, picoline, quinoline, piperdine, pyrrolidine, N-methylmorphline, amine such
as triethylamine and diisopropyl amine and combination thereof. Preferably the base is lithium hydroxide.
[0061] The strontium salt may be selected from strontium chloride, strontium bromide, strontium sulfate, strontium acetate, strontium carbonate, strontium oxalate, strontium nitrate and a mixture thereof. Preferably the strontium salt is strontium chloride hexahydrate.
[0062] The above reaction mixture is stirred for a period of about 10 hours to about 30 hours. Preferably, the reaction mixture is stirred for about 15 hours to about 20 hours. The reaction transpires at a temperature of about 25°C to about 30°C. The precipitate of distrontium salt of 5-[bis (carboxymethyl) amino]-2-carboxy-4-cyano-3- thiopheneacetic acid octahydrate can be isolated by techniques known in the art such as filtration, centrifugation.
[0063] In one embodiment, the present invention provides process for the preparation of amorphous strontium ranelate from ranelic acid, comprising reacting ranelic acid with anhydrous strontium salt in the presence of base.
[0064] In one embodiment, the ranelic acid used is the unsolvated form.
Preferably hydrate of ranelic acid.
[0065] The base may be selected from inorganic or organic bases such as hydroxides, carbonates, bicarbonates. Preferably the inorganic base is lithium hydroxide. The organic bases may be selected from the group consisting of amine, pyridine, picol ine, quinoline, piperidine, pyrrolidine, N-methylmorphline, and combination thereof. Preferably the base is diisopropyl amine.
[0066] The above reaction may be carried out in presence of water miscible solvents for example alcoholic solvents such as methanol, ethanol, isopropanol and the like. Preferably the solvent is methanol.
[0067] The strontium salt may be selected from strontium chloride, strontium bromide, strontium sulfate, strontium acetate, strontium carbonate, strontium oxalate, strontium nitrate and a mixture thereof. Preferably the strontium salt is strontium chloride anhydrous.
[0068] In a preferred embodiment, strontium chloride anhydrous is dissolved in methanol and to this diisopropyl amine is added. Then this solution is added to a solution of ranelic acid in methanol. The reaction is stirred and maintained for a period of about 30 hours to about 50 hours. Preferably the reaction is stirred and maintained for about 45 hours to 49 hours.
[0069] The precipitate of distrontium salt of 5-[bis (carboxymethyl) amino]-2- carboxy-4-cyano-3-thiopheneacetic acid can be isolated by techniques known in the art such as filtration, centrifugation.
[0070] In one embodiment, amorphous strontium ranelate is characterized by an X-ray diffraction pattern, substantially in accordance with Fig. 4.
In one embodiment amorphous strontium ranelate is characterized by thermogravimetric analysis, (TGA) thermogram, which is substantially in accordance with Fig 5., shows a weight loss of 14.5 percent up to a temperature of about 150°C and recorded on a TGA Q500 V 20.6 in a platinum pan with a temperature rise of about 10°C per minute in the range of about 30°C to about 350°C.
[0071] In one embodiment, the present invention relates to a process for purification of strontium ranelate comprising treatment of strontium ranelate with water or an organic
acid, for example, acetic acid, lactic acid, malonic acid, tartaric acid, oxalic acid or a mixture thereof. Preferably, the acid is oxalic acid, advantageously to be used as 1 % aqueous solution.
[0072] The purification can be carried out preferably by subjecting to a slurrying step carried out at temperature between the range of about 15°C to about 40°C, preferably at about 20°C to about 30°C resulting into removal of lithium.
[0073] In one embodiment, the present invention relates to strontium ranelate containing lithium content less than 60 parts per million (ppm).
[0074] In one embodiment, the present invention relates to strontium ranelate containing lithium content less than 20 parts per million (ppm).
[0075] In one embodiment, the present invention relates to strontium ranelate containing lithium content less than 10 parts per million (ppm).
[0076] Strontium ranelate obtained from ranelic acid of the present invention has purity greater than 99.0% as measured by high performance liquid chromatography (HPLC).
[0077] While the present invention has been described in terms of its speci fic embodiments, certain modifications and equivalents will be apparent to those ski lled in the art and are intended to be included within the scope of the present invention.
[0078] The examples that follow, are not intended to be limiting of the scope of the present invention but read in conjunction with the detailed and general description above, to provide further understanding of the present invention and an outline of processes for preparation.
EXAMPLES:
Example 1 Preparation of ranelic acid.
[0079J In a 2 lit 4-neck round bottom flask equipped with overhead stirrer, double surface condenser, thermowel pocket placed in oil bath a solution of methyl 5- [bis(2-ethoxy-2-oxoethyl) amino]-4-cyano-3-(2-methoxy-2-oxoethyI)-2-thiphene-carboxy- late ( 150g,0.35 mol) was prepared in tetrahydrofuran (450ml). Slowly a solution of lithium hydroxide (66.0 g in 600 ml water) is added to the above solution of ester at about 5- 10°C. The reaction mass was stirred for about 22 hours at about 5- 10°C. The two layers formed were separated. The lower layer was acidified with 10% sulfuric acid to bring the pH to about less than 1 . The reaction mass was further stirred for about 30 minutes. Then the reaction mass was extracted with ethyl acetate. Ethyl acetate layers were pooled and distilled to obtain solid ranelic acid.
Dry weight of ranelic acid 1 15 g (Yield: 95%, HPLC purity: 99. 12%), melting range: 146.4°C to 147.4°C; TGA: weight loss of 9.39 percent upto a temperature of 100°C.
[0080J Example 2 Preparation of 5-[bis (carboxymethyl) amino]-2-carboxy-4- cyano-3-thiopheneacetic acid distrontium salt
In a 500 ml 4-neck round bottom flask equipped with overhead stirrer, double surface condenser, thermowel pocket placed in oil bath, a solution of ranelic acid (5 g) in water (45 ml) was prepared. To this solution, 10% w/v aqueous lithium hydroxide solution (27.5 ml) was added and the reaction mass was stirred at about 25-30°C. A solution of strontium chloride hexahydrate (8.57 g) in water (85 ml) was added to the above solution at about 25-30 °C. This reaction mixture was stirred for about 15 hours to about 20 hours at about 25-30°C. The precipitated solid, distrontium salt of 5-[bis (carboxymethyl) amino]-2-carboxy-4-cyano-3-thiopheneacetic acid was filtered and washed with water. The resulting wet material was dried at about 30-35 °C under reduced pressure. Yield 7.8 g of strontium ranelate octahydrate. purity > 99.0% as determined by HPLC.
Strontium ranelate octahydrate (50 g) was suspended in purified water (500 ml), and the contents were stirred at 25-30 °C for 10 min. To this 1 .0% oxalic acid (0.5 g) was added and the content was stirred for 4.0 h at 25-30°C. The product was filtered and
washed with purified water. The wet cake was added into purified water and the content was stirred for 1 .0 h at 25-30°C. The product was filtered and washed with puri fied water. The product was dried at 30°C -35°C under reduced pressure (~20mm Hg) to obtain 45g of strontium ranelate (0.9 w/w based on strontium ranelate octahydrate). Li content< 13 ppm. Loss on drying not more than 23.5%, HPLC purity>99%.
[0081] Example 3 Preparation of amorphous 5-[bis (carboxymethyl) amino]-
2-carboxy-4-cyano-3-thiopheneacetic acid distrontium salt.
In a 250ml 4-neck round bottom flask equipped with overhead stirrer, double surface condenser, thermowel pocket placed in oil bath a solution of anhydrous strontium chloride (4.63gm) was prepared in methanol ( 150ml) under nitrogen atmosphere. To this diisopropyl amine was added and the reaction mass was stirred for 15 minutes. The above reaction mass was added to a solution of ranelic acid (5gm) in methanol. The reaction was stirred for 48 hours and the precipitated product was filtered and washed with methanol under nitrogen atmosphere. The product was dried at about 35-40°C under reduced pressure (~10mm Hg) to obtain 3.9gm of amorphous strontium ranelate. HPLC purity>98%, TGA: weight loss of 14.5 percent upto a temperature of 150°C.
Claims
1 . Unsolvated solid ranelic acid.
2. The compound of claim 1 , wherein the compound is a hydrate and is characterized by at least any one of the following:
a) XRD powder diffraction pattern having characteristics peaks expressed in degrees 2Θ ±0.2° at about 1 3.3, 14.59, 21.19, 26.24;
b) DSC thermogram having one endothermic peak at 78.39°C and another peak at 154.68°C; and
c) TGA thermogram showing a weight loss of about 9.39 percent up to a temperature of 100°C.
3. A process for the preparation of ranelic acid comprising:
a) reacting a tetraester of formula II
wherein R, R| , R2, and R3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, with a base in a solvent to obtain a reaction mixture; and
b) subjecting the reaction mixture to treatment with an acid to precipitate ranelic acid.
4. The process of claim 3, wherein R, R| , R2, and R3 of the tetraester of Formula II are independently a linear or branched Ci-C alkyl group.
5. The process of claim 3, wherein R, Ri , R2, and R3 of the tetraester of Formula I I are independently methyl or ethyl.
6. The process of claim 3, wherein R, R] , R2, and R3 of the tetraester of Formula II are ethyl.
7. The process of claim 3, wherein the base is an inorganic base such as hydroxide base selected from the group consisting of lithium hydroxide, lithium carbonate, lithium hydroxide monohydrate, calcium hydroxide, cesium hydroxide and mixtures thereof.
8. The process of claim 3, wherein the solvent is selected from the group consisting of water, water miscible organic solvent and mixtures thereof.
9. The process of claim 3, wherein the water miscible organic solvent is selected from the group consisting of cyclic ether, water, ketone, nitrile and mixtures thereof.
10. The process of claim 3, wherein acid is a mineral acid selected from sulfuric acid, hydrochloric acid, hydrobromic acid.
1 1 . The process of claim 9 wherein the cyclic ether is tetrahydrofuran, dioxane and mixtures thereof.
12. A process of precipitating ranelic acid comprising:
a) reacting a tetraester of formula II
wherein R, R\ , R2, and R3 are independently a linear or branched C 1 -C6 alkyl group or a substituted or unsubstituted C3-C 12 cyclic group, with a base in a solvent to obtain a reaction mixture;
and b) subjecting the reaction mixture to treatment with acid to adjust pH of reaction mixture to 1 or less than 1 .
13. The process of claim 3 wherein ranelic acid has purity greater than 98%.
14. The process of claim 13 wherein ranelic acid has purity greater than 99%.
1 5. A process for preparation of strontium ranelate comprising reacting ranelic acid with strontium salt in the presence of a base.
16. A process for purifying strontium ranelate comprising treating strontium ranelate with an organic acid and or water.
17. The process of claim 16, wherein the ranelic acid is isolated solid ranelic acid.
1 8. Strontium ranelate containing lithium content less than 60 ppm.
19. The compound of claim 1 characterized by at least any one of the following:
a) XRD characterized by XRD pattern, substantially in accordance with Fig. 1 ; b) DSC thermogram substantially in accordance with Fig.2;
c) TGA thermogram, substantially in accordance with Fig.3.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN2801MU2010 | 2010-10-08 | ||
| IN2801/MUM/2010 | 2010-10-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012046251A2 true WO2012046251A2 (en) | 2012-04-12 |
| WO2012046251A3 WO2012046251A3 (en) | 2012-06-07 |
Family
ID=45928170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2011/000696 Ceased WO2012046251A2 (en) | 2010-10-08 | 2011-10-05 | Novel form of ranelic acid |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012046251A2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2651497B1 (en) * | 1989-09-01 | 1991-10-25 | Adir | NOVEL SALTS OF BIVALENT METALS OF N, N-DI ACID (CARBOXYMETHYL) AMINO-2 CYANO-3 CARBOXYMETHYL-4 CARBOXY-5 THIOPHENE, THEIR PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| US8624041B2 (en) * | 2005-08-19 | 2014-01-07 | Glenmark Generics Ltd. | Process for the preparation of strontium ranelate |
| FR2921367B1 (en) * | 2007-09-26 | 2009-10-30 | Servier Lab | NEW PROCESS FOR THE SYNTHESIS OF STRONTIUM RANELATE AND ITS HYDRATES |
| RU2011116926A (en) * | 2008-09-29 | 2012-11-10 | Рациофарм ГмбХ (DE) | Anhydrous and hydrate forms of strontium ranelate |
-
2011
- 2011-10-05 WO PCT/IN2011/000696 patent/WO2012046251A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012046251A3 (en) | 2012-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3812748B2 (en) | Method for producing sufentanil derivative by carbene addition / aminolysis of 4-piperidone | |
| US11897843B2 (en) | Process for the preparation of enantiomerically enriched 3-aminopiperidine | |
| JP5863789B2 (en) | Method for producing pyrazole derivative | |
| WO2006071868A2 (en) | Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof | |
| US8614337B2 (en) | S-5-substituent-N-2′-(thiophene-2-yl)ethyl-tetralin-2-amine or chiral acid salts thereof and use for preparing Rotigotine | |
| CN116332919B (en) | A preparation method of ALK inhibitor compound and intermediate thereof | |
| CN103601645B (en) | The preparation method of 1-(phenethyl amino) propane-2-alcohol compound or its salt | |
| TWI835325B (en) | Preparation method of (S)-4-chloro-2-aminobutyric acid hydrochloride and (S)-4-chloro-2-aminobutyric acid ester | |
| WO2009062036A2 (en) | Processes for preparing levocetirizine and pharmaceutically acceptable salts thereof | |
| WO2012046251A2 (en) | Novel form of ranelic acid | |
| US9745264B2 (en) | Method for preparing silodosin and intermediate thereof | |
| WO2006018955A1 (en) | Process for the production of isoindole derivatives | |
| EP2376470B1 (en) | Process for the preparation of (6s)-(-)-5,6,7,8-tetrahydro-6-[propyl-(2-thienyl)ethyl]amino-1-naphthol (rotigotine) | |
| WO2008134923A1 (en) | A preparation method of thiol derivative as side chain intermediate for synthesis of carbapenem derivative | |
| NZ570633A (en) | Flurophenoxy-piperazine derivatives | |
| WO2004039785A1 (en) | Process for the preparation of pyrrolidinyl ethylamine compounds via a copper-mediated aryl amination | |
| WO2023016249A1 (en) | Method for preparing 3-aryloxy-3-five-membered heteroaryl-propylamine compound | |
| US8946433B2 (en) | Process for the preparation of sufentanil base and related compounds | |
| EP1968965A2 (en) | A METHOD FOR THE PREPARATION OF (S)-N-METHYL-3-(l-NAPHTHYLOXY)-3-(2-THIENYL)PROPYLAMINE HYDROCHLORIDE (DULOXETINE) | |
| EP1805168A1 (en) | Process for preparing substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds | |
| WO2008061688A1 (en) | 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders | |
| CN100341850C (en) | Salts of demethyl phencynonate isomer and N-para-methyl-phenyl-sulfuryl glutamic acid optical isomer and their preparing method and use | |
| WO2010086878A2 (en) | Thyroid receptor modulators | |
| CN110128339A (en) | The synthetic method and synthesis intermediate of a kind of datro and its salt derivative | |
| WO2013175270A1 (en) | Improved process for the preparation of strontium ranelate hydrates and new polymorphic form of monohydrate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11830294 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 11830294 Country of ref document: EP Kind code of ref document: A2 |